Qube Research & Technologies (QRT)
EW icon

Qube Research & Technologies (QRT)’s Edwards Lifesciences EW Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,900
Closed -$232K – 3646
2026
Q1 		$232K Sell
2,900
-2,300
-44% -$190K ﹤0.01% 2920
2025
Q4 		$443K Sell
5,200
-6,400
-55% -$525K ﹤0.01% 2836
2025
Q3 		$902K Sell
11,600
-7,300
-39% -$570K ﹤0.01% 2565
2025
Q2 		$1.48M Buy
18,900
+14,200
+302% +$1.06M ﹤0.01% 2317
2025
Q1 		$341K Buy
4,700
+3,700
+370% +$265K ﹤0.01% 2694
2024
Q4 		$74K Sell
1,000
-900
-47% -$63K ﹤0.01% 3037
2024
Q3 		$125K Buy
+1,900
New +$138K ﹤0.01% 2699
2023
Q4 		– Sell
-5,200
Closed -$360K – 4455
2023
Q3 		$360K Buy
+5,200
New +$418K ﹤0.01% 2166

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EW Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Edwards Lifesciences (EW) stake by 48% in Q2 2026, selling an estimated $31.9M and leaving 414,438 shares worth $37.5M. The position accounts for 0.03% of the portfolio, ranked #607.

Qube Research & Technologies (QRT) first reported a position in EW in Q3 2018 and has held it in 23 quarters since. The position peaked at $95.1M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Qube Research & Technologies (QRT) held 414,438 shares of Edwards Lifesciences worth $37.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 380,750 Edwards Lifesciences shares in Q2 2026, an estimated $31.9M.
  • Edwards Lifesciences made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #607 holding.
  • Qube Research & Technologies (QRT) first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 23 quarters since.
  • Qube Research & Technologies (QRT)'s Edwards Lifesciences position peaked at $95.1M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.